B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental injection targets tough blood cancers and anemia
Disease control Recruiting nowThis early-stage study tests a new treatment called GT801 in 28 adults with certain blood cancers (like leukemia and lymphoma) or an autoimmune blood disorder (AIHA) that have not responded to standard therapies. The treatment uses specially modified cells to target a protein cal…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
New hope for tough leukemia: experimental drug AZD0486 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called AZD0486 in adolescents and adults whose B-cell acute lymphoblastic leukemia has come back or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink or eliminate the cancer. About 163 parti…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New hope for kids with tough leukemia: smarter CAR T-Cell production under trial
Disease control Recruiting nowThis study tests a new way to make special immune cells (CAR T-cells) for children with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. The goal is to see if this new manufacturing method is safe and works better. About 89 children will take …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New cell therapy JY231 targets tough leukemia in early human test
Disease control Recruiting nowThis early-phase study tests a new treatment called JY231 for people with B-cell acute lymphoblastic leukemia (B-ALL), a fast-growing blood cancer. The main goals are to check safety and find the right dose. About 20 adults whose cancer has CD19 on their cells can join. This is a…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New hope for relapsed leukemia: experimental drug AZD4512 enters human trials
Disease control Recruiting nowThis study tests a new drug called AZD4512 in people with a hard-to-treat blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to other treatments. The goal is to see if the drug is safe and how well it works, either alone or with ot…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
CAR T-Cell survivors: what happens years later?
Knowledge-focused Recruiting nowThis study looks at the long-term health and quality of life of children, teens, and young adults who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia. Researchers will check for late side effects, thinking skills, immune function, and daily abilities in surviv…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 04:30 UTC
-
Study seeks to solve vaccine puzzle for kids treated for blood cancer
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) who received blinatumomab for B-cell acute lymphoblastic leukemia still have protection from their childhood vaccines. Researchers will test antibody levels for diseases like tetanus, hepatitis B, and measles. I…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:54 UTC